Curcumin Targets Multiple Pathways to Halt Hepatic Stellate Cell Activation: Updated Mechanisms In Vitro and In Vivo
Author:
- 23 December 2014
- journal article
- review article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (6) , 1554-1564
Abstract
Nonalcoholic steatohepatitis (NASH) is the advanced form of nonalcoholic fatty liver disease, which is often accompanied by obese and/or type II diabetes mellitus. Approximately one-third of NASH patients develop hepatic fibrosis. Hepatic stellate cells are the major effector cells during liver fibrogenesis. Advanced liver fibrosis usually proceeds to cirrhosis and even hepatocellular carcinoma, leading to liver failure, portal hypertension and even death. Currently, there are no approved agents for treatment and prevention of liver fibrosis in human beings. Curcumin, the principal curcuminoid of turmeric, has been reported to show antitumor, antioxidant, and anti-inflammatory properties both in in vitro and in vivo systems. Accumulating data shows that curcumin plays a critical role in combating liver fibrogenesis. This review will discuss the inhibitory roles of curcumin and update the underlying mechanisms by which curcumin targets in inhibiting hepatic stellate cell activation.Keywords
This publication has 127 references indexed in Scilit:
- Curcumin eliminates the inhibitory effect of advanced glycation end-products (AGEs) on gene expression of AGE receptor-1 in hepatic stellate cells in vitroLaboratory Investigation, 2012
- Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2Molecular and Cellular Endocrinology, 2011
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2011
- Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter‐4 and increasing glucokinaseBritish Journal of Pharmacology, 2010
- Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1Laboratory Investigation, 2009
- In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-αJournal of Clinical Investigation, 2009
- Curcumin suppresses expression of low‐density lipoprotein (LDL) receptor, leading to the inhibition of LDL‐induced activation of hepatic stellate cellsBritish Journal of Pharmacology, 2009
- PPARγ and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scaleGenes & Development, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- CURCUMIN: THE INDIAN SOLID GOLD2007